Infectious Diseases Search
Infectious Diseases Infectious Diseases
rosacea
ROSACEA
Treatment Guideline Chart
Rosacea is a chronic inflammatory cutaneous disease of the convexities of the central face (cheeks, chin, nose and central forehead) and eyes with periorbital and perioral skin sparing. This condition is attributed to chronic vasodilation.
Remissions and exacerbations are common.
It typically begins after 30 years of age but may occur at any age.  It commonly affects fair-skinned individuals.
The common presenting symptoms are facial flushing, stinging/burning erythema, telangiectasia, edema, papules, pustules, ocular lesions, and hypertrophy of the sebaceous glands of the nose with fibrosis (rhinophyma).
A history of episodic flushing often heralds onset of rosacea.

Rosacea References

  1. Blount WB, Pelletier AL. Rosacea: a common, yet commonly overlooked, condition. Am Fam Physician. 2002 Aug;66(3):435-440. PMID: 12182520
  2. Cohen AF, Tiemstra JD. Diagnosis and treatment of rosacea. J Am Board Fam Pract. 2002 Jun;15(3):214-217. PMID: 12038728
  3. Dahl MV, Jarratt M, Kaplan D, et al. Once-daily topical metronidazole cream formulations in the treatment of the papules and pustules of rosacea. J Am Acad Dermatol. 2001 Nov;45(5):723-730. PMID: 11606923
  4. Elewski BE, Fleischer AB, Pariser DM. A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea. Arch Dermatol. 2003 Nov;139(11):1444-1450. PMID: 14623704
  5. Dahl MV, Katz IH, Krueger GG, et al. Topical metronidazole maintains remissions of rosacea. Arch Dermatol. 1998 Jun;134(6):679-683. PMID: 9645635
  6. Goldgar C, Keahey D, Houchins J. Treatment options for acne rosacea. Am Fam Physician. 2009 Sep;80(5):461-468. PMID: 19725487
  7. Landow K. Unraveling the mystery of rosacea. Postgrad Med. 2002 Dec;112(6):51-58. PMID: 12510446
  8. Liu RH, Smith MK, Basta SA, et al. Azelaic acid in the treatment of papulopustular rosacea. Arch Dermatol. 2006 Aug;142(8):1047-1052. PMID: 16924055
  9. Maddin S. A comparison of topical azelaic acid 20% cream and topical metronidazole 0.75% cream in the treatment of patients with papulopustular rosacea. J Am Acad Dermatol. 1999 Jun;40:961-965. PMID: 10365928
  10. Powell FC. Clinical Practice. Rosacea. N Engl J Med. 2005 Feb;352(8):793-803. PMID: 15728812
  11. Rebora A. The management of rosacea. Am J Clin Dermatol. 2002;3(7):486-496. PMID: 12180896
  12. Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol. 2002 Apr;46(4):584-587. PMID: 11907512
  13. Thiboutot DM. Acne and rosacea. New and emerging therapies. Dermatol Clin. 2000 Jan;18(1):63-71. PMID: 10626112
  14. Wilkin J, Dahl M, Detmar M, et al. Standard grading of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol. 2004 Jun;50(6):907-912. PMID: 15153893
  15. Wilkin JK, DeWitt S. Treatment of rosacea: topical clindamycin versus oral tetracycline. Int J Dermatol. 1993 Jan;32(1):65-67. PMID: 8425809
  16. Zuber TJ. Rosacea. Prim Care. 2000 Jun;27(2):309-318. PMID: 10815045
  17. Habif TP. Rosacea (acne rosacea). Clinical Dermatology. 3rd ed: Mosby-Year Book Inc; 1996
  18. MedWorm http://www.medworm.com/rss/index.php/Dermatology/12/ http://www.medworm.com/rss/medicalfeeds/specialities/Dermatology-News.xml
  19. MedWormhttp://www.medworm.com/rss/index.php/Pediatrics/33/http://www.medworm.com/rss/medicalfeeds/specialities/Pediatrics.xml
  20. Kim J. Acne and Rosacea getting you down? Laser, light and cosmetic treatments give patients a much-needed boost. Bio-Medicine. http://www.bio-medicine.org/medicine-news-1/Acne-And-Rosacea-Getting-You-Down-3F-Laser--Light-And-Cosmetic-Treatments-Give-Patients-A-Much-Needed-Boost-10815-1/. Feb 2003
  21. Rouzeau V, Pelegrin G. Coping with rosacea: a guide from triggers to treatments. Pharmacy Times. http://www.pharmacytimes.com/publications/issue/2011/May2011/-Coping-with-Rosacea-A-Guide-from-Triggers-to-Treatments. May 2011. Accessed 13 Aug 2013.
  22. Rosacea. Primary Care Dermatology Society. http://website.http://www.pcds.org.uk/clinical-guidance/rosacea.Updated. Mar 2013. Accessed 13 Aug 2013.
  23. Rosacea - treatment. NHS choices. http://www.nhs.uk/Conditions/Rosacea/Pages/Treatment.aspx. Mar 2012. Accessed 14 Aug 2013.
  24. American Academy of Dermatology. Rosacea treatment. RosaceaNet. http://www.skincarephysicians.com
  25. Gooderham M. Rosacea and its topical management. Skin Therapy Letter.com. www.skintherapyletter.com/2009/14.2/1.html. Jun 2012. Accessed 14 Aug 2013.
  26. Abokwidir M, Feldman SR. Rosacea management. Skin Appendage Disord. 2016;2:26-34. doi: 10.1159/000446215.
  27. Dahl MV. Rosacea: pathogenesis, clinical features and diagnosis. UpToDate. http://www.uptodate.com. Apr 2019.
  28. Del Rosso JQ, Thiboutot D, Gallo R, et al. Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 1: a status report on the disease state, general measures and adjunctive skin care. Cutis. 2013 Nov;92(5):234-240. PMID: 24343208
  29. Del Rosso JQ, Thiboutot D, Gallo R, et al. Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 2: a status report on topical agents. Cutis. 2013 Dec;92(6):277-284. PMID: 24416742
  30. Del Rosso JQ, Thiboutot D, Gallo R, et al. Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 3: a status report on systemic agents. Cutis. 2014 Jan;93(1):18-28. PMID: 24505581
  31. Del Rosso JQ, Thiboutot D, Gallo R, et al. Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 5: a guide on the management of rosacea. Cutis. 2014 Mar;93(3):134-138. PMID: 24738094
  32. Gallo RL, Granstein RD, Kang S, et al. Standard classification and pathophysiology of rosacea: the 2017 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol. 2018 Jan;78(1):148-155. doi: 10.1016/j.jaad.2017.08.037. PMID: 29089180
  33. Kelly KM. Laser and light therapy for cutaneous vascular lesions. UpToDate. http://www.uptodate.com. Apr 2018.
  34. Maier LE. Management of rosacea. UpToDate. http://www.uptodate.com. Oct 2018.
  35. Oge LK, Muncie HL, Phillips-Savoy AR. Rosacea: diagnosis and treatment. Am Fam Physician. 2015 Aug;92(3):187-196. PMID: 26280139
  36. Rivero AL, Whitfield M. An update on the treatment of rosacea. Aust Prescr. 2018 Feb;41(1):20-24. doi: 10.18773/austprescr.2018.004. PMID: 29507456
  37. Schaller M, Almeida LM, Bewley A, et al. Rosacea treatment update: recommendations from the global ROSacea COnsensus (ROSCO) panel. Br J Dermatol. 2017 Feb;176(2):465-471. doi: 10.1111/bjd.15173. PMID: 27861741
  38. Tan J, Almeida LM, Bewley A, et al. Updating the diagnosis, classification and assessment of rosacea: recommendations from the global ROSacea COnsensus (ROSCO) panel. Br J Dermatol. 2017 Feb;176(2):431-438. doi: 10.1111/bjd.15122. PMID: 27718519
  39. Tanghetti E, Del Rosso JQ, Thiboutot D, et al. Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 4: a status report on physical modalities & devices. Cutis. 2014 Feb;93(2):71-76. PMID: 24605343
  40. Tüzün Y, Wolf R, Kutlubay Z, et al. Rosacea and rhinophyma. Clin Dermatol. 2014 Jan;32(1):35-46. doi: 10.1016/j.clindermatol.2013.05.024. PMID: 24314376
  41. Two AM, Wu W, Gallo RL, et al. Rosacea: part II. Topical and systemic therapies in the treatment of rosacea. J Am Acad Dermatol. 2015 May;72(5):761-770. doi: 10.1016/j.jaad.2014.08.027. PMID: 25890456
  42. Weinkle AP, Doktor V, Emer J. Update on the management of rosacea. Clin Cosmet Investig Dermatol. 2015 Apr;8:159-177. doi: 10.2147/CCID.S58940. PMID: 25897253
  43. Thiboutot D, Anderson R, Cook-Bolden F, et al. Standard management options for rosacea: the 2019 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol. 2020 Jun;82(6):1501-1510. doi: 10.1016/j.jaad.2020.01.077. PMID: 32035944
Editor's Recommendations
Special Reports
MORE Special Reports arrow